KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group

Amy K. Erbe, Mitch B. Diccianni, Rajen Mody, Arlene Naranjo, Fan F. Zhang, Jen Birstler, Kyungmann Kim, Arika S. Feils, Jung Tung Hung, Wendy B. London, Barry L. Shulkin, Varsha Mathew, Marguerite T. Parisi, Sabah Servaes, Shahab Asgharzadeh, John M. Maris, Julie Park, Alice L. Yu, Paul M. Sondel, Rochelle Bagatell

Biostatistics

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

4 Citas (Scopus)

1 resultados
- Título
- Fecha(ascendente)

Researchers' from University of Michigan Report Details of New Studies and Findings in the Area of Neuroblastomas (KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory ...)
Naranjo, A.
15/3/23
1 elemento de Cobertura del medio de comunicación
Prensa/medios de comunicación: !!!Research

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group

Prensa/Medios de comunicación

Resultados de la búsqueda

Researchers' from University of Michigan Report Details of New Studies and Findings in the Area of Neuroblastomas (KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory ...)